A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source
Viral infections in celiac disease: what should be considered for better management. [PDF]
Asri N +5 more
europepmc +1 more source
Objective Cardiovascular events are major determinants of morbidity and mortality in systemic lupus erythematosus (SLE), particularly in patients with renal involvement. While oxidative stress has been implicated in driving vascular and renal damage in SLE, the specific mechanisms remain unclear.
Matteo Becatti +13 more
wiley +1 more source
Challenges of concurrent HIV infection in the course and management of Crohn's disease. [PDF]
Mattar L +8 more
europepmc +1 more source
Demonstration, and a Suggested Immune Role, of Mouse Antibodies against Salmonella enteritidis Endotoxins [PDF]
Barrack, Jimmie D., Paulissen, Leo J.
core +2 more sources
IgA Antibodies to Bovine Serum Albumin in Adult Patients with Celiac Disease. [PDF]
Savvateeva E +13 more
europepmc +1 more source
Similarities and Differences in the Immune Characteristics of Intestinal Gamma Delta T Cells From Patients With Crohn's Disease and Ulcerative Colitis and Their Correlation With Disease Activity. [PDF]
Jiang Y +7 more
europepmc +1 more source
Diagnostic Challenges in Enteropathies: A Histopathological Review. [PDF]
Enache I +5 more
europepmc +1 more source
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. [PDF]
Brettschneider, L +5 more
core

